# Meningeal metastatic tumor with bone destruction from follicular thyroid carcinoma: a case report and literature review

**Authors:** Wei Liu, Lanming Su, Qinglu Zhang, Yuanqin Liu

PMC · DOI: 10.3389/fsurg.2025.1708113 · Frontiers in Surgery · 2026-01-06

## TL;DR

This paper reports a rare case of meningeal metastasis from follicular thyroid carcinoma and reviews similar cases in the literature.

## Contribution

The paper adds a new case to the limited literature on meningeal metastasis from follicular thyroid carcinoma and reviews existing cases.

## Key findings

- Meningeal metastasis from FTC is rare and often misdiagnosed as meningioma.
- Gross-total resection provides favorable initial control, but recurrence is possible.
- Long-term prognosis remains uncertain due to the small number of reported cases.

## Abstract

Follicular thyroid carcinoma (ftc) is a malignant neoplasm arising from thyroid follicular epithelial cells and is the second most common thyroid cancer after papillary thyroid carcinoma. meningeal metastasis from ftc with calvarial destruction is exceedingly rare and is often misdiagnosed clinically as meningioma. we reviewed previously reported cases in the literature and, in addition, report and include one case of meningeal metastasis from ftc treated at our center.

Using the keywords “meningioma,” “follicular thyroid carcinoma,” and “cerebral metastatic tumor,” we searched PubMed/MEDLINE and Web of Science to identify relevant publications. We extracted patient age, sex, tumor location and size, treatment modalities, and follow-up outcomes. In parallel, we provide a detailed description and analysis of the clinical course of the present case.

A total of 10 patients were included, comprising the cases reported in the literature and the index case in this study. The mean age was 60.5 years, and most lesions were solitary epidural or dural-based masses. Headache was the most common presenting symptom. All patients underwent surgical resection; postoperative recurrence occurred in two cases, and the longest survival on follow-up was 7 years.

Meningeal metastasis from FTC is rare and typically presents as a dural-based mass that readily mimics meningioma. Gross-total resection can achieve favorable initial disease control, although recurrence may still occur. Given the small number of reported cases, the long-term prognosis remains uncertain and warrants further investigation.

## Linked entities

- **Diseases:** follicular thyroid carcinoma (MONDO:0005034), meningioma (MONDO:0003057), meningeal metastasis (MONDO:0700219)

## Full-text entities

- **Genes:** GFAP (glial fibrillary acidic protein) [NCBI Gene 2670] {aka ALXDRD}, SYNM (synemin) [NCBI Gene 23336] {aka DMN, SYN}, PGR (progesterone receptor) [NCBI Gene 5241] {aka NR3C3, PR}, CMPK1 (cytidine/uridine monophosphate kinase 1) [NCBI Gene 51727] {aka CK, CMK, CMPK, UMK, UMP-CMPK, UMPK}, NKX2-1 (NK2 homeobox 1) [NCBI Gene 7080] {aka BCH, BHC, NK-2, NKX2.1, NKX2A, NMTC1}, CD34 (CD34 molecule) [NCBI Gene 947], TPO (thyroid peroxidase) [NCBI Gene 7173] {aka MSA, TDH2A, TPX}, SYP (synaptophysin) [NCBI Gene 6855] {aka MRX96, MRXSYP, XLID96}, SSTR2 (somatostatin receptor 2) [NCBI Gene 6752] {aka SST2}, CALCA (calcitonin related polypeptide alpha) [NCBI Gene 796] {aka CALC1, CGRP, CGRP-I, CGRP-alpha, CGRP1, CT}, MUC1 (mucin 1, cell surface associated) [NCBI Gene 4582] {aka ADMCKD, ADMCKD1, ADTKD2, CA 15-3, CD227, Ca15-3}, TTF1 (transcription termination factor 1) [NCBI Gene 7270] {aka TTF-1, TTF-I}, TG (thyroglobulin) [NCBI Gene 7038] {aka AITD3, TGN}, S100A1 (S100 calcium binding protein A1) [NCBI Gene 6271] {aka S100, S100-alpha, S100A}
- **Diseases:** hypertension (MESH:D006973), endocrine malignancy (MESH:D004700), brain metastases (MESH:D001932), skull erosion (MESH:D014077), blood loss (MESH:D016063), vomiting (MESH:D014839), PTC (MESH:D000077273), dural disease (MESH:D020785), thyroid nodules (MESH:D016606), Meningioma (MESH:D008579), infection (MESH:D007239), DTC (MESH:D013964), blurred vision (MESH:D014786), hearing loss (MESH:D034381), visual field deficits (MESH:D005128), adenocarcinoma (MESH:D000230), osteolysis (MESH:D010014), lymphoma (MESH:D008223), bleeding (MESH:D006470), anosmia (MESH:D000857), cerebral metastatic tumor (MESH:D009369), seizures (MESH:D012640), motor dysfunction (MESH:D000068079), DTC/FTC (MESH:C572845), SFT/HPC (MESH:D054364), deaths (MESH:D003643), vascular malformations (MESH:D054079), exophthalmos (MESH:D005094), dural metastasis of thyroid carcinoma (MESH:D009362), medullary thyroid carcinoma (MESH:C536914), bone destruction (MESH:D001847), limb weakness (MESH:D018908), Headache (MESH:D006261), dizziness (MESH:D004244), based (MESH:D019292), nausea (MESH:D009325), diabetes (MESH:D003920), CNS neoplasms (MESH:D016543), neurological injury (MESH:D020196), osseous (MESH:C535395), meningeal (MESH:D008580), paresthesia (MESH:D010292), dysarthria (MESH:D004401), ATC (MESH:D002277), FTC (MESH:D018263), coronary artery disease (MESH:D003324), necrosis (MESH:D009336), medullary carcinoma (MESH:D018276)
- **Chemicals:** triiodothyronine (MESH:D014284), RAI (-), thyroxine (MESH:D013974)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12816310/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12816310/full.md

## References

24 references — full list in the complete paper: https://tomesphere.com/paper/PMC12816310/full.md

---
Source: https://tomesphere.com/paper/PMC12816310